NCT06049108View on ClinicalTrials.gov

A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

November 3, 2023

Study Completion Date

November 3, 2023

Conditions
Healthy
Interventions
DRUG

[14C]-LY3871801

Administered orally

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06049108 - A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants | Biotech Hunter | Biotech Hunter